The parternship's first launch will be a vitamin D concept under MHN’s brand Selex, powered by Hologram Science’s d.velop holistic immunity platform.
Hologram Sciences (Boston), backed by Royal DSM, and Maeil Health Nutrition (MHN; Seoul, Korea) entered into a strategic partnership to deliver personalized nutrition solutions to the Korean market. Maeil will expand its offerings through a license with Hologram for its holistic immunity brand called d.velop. The parternship's first launch will be a vitamin D concept under MHN’s brand Selex, powered by Hologram Science’s d.velop holistic immunity platform. This includes easy and convenient at-home testing kits, supplementation delivery, and a digital service incorporating one-to-one coaching and actionable insights.
“We are delighted to be entering this landmark licensing partnership with MHN, our first in Asia,” said Ian Brady, CEO of Hologram Sciences, in a press release. “With their outstanding track record and leading position in functional nutrition, MHN is a perfect fit to bring our personalized health and wellness solutions to consumers in Korea.”
Hologram's d.velop leverages the ingredient ampli-D calcifediol from DSM and will be offered in a range of supplement formats. MHN will also gain access to Hologram Sciences’ other brands in the Korean market, including Phenology, a menopause-focused women's health solution.
“Personalized health and wellness is a critically important trend in our market as is the increasing need for holistic digital solutions, and we are excited to be partnering with Hologram Sciences, a true pioneer in the personalized nutrition field,” said Seon Hee Kim, CEO of Maeil Health Nutrition, in a press release. “We are already exclusive distributors of global premium food brands such as Ferrero and Arla in Korea and we look forward to working with Hologram Sciences as our exclusive health and personalized nutrition partner.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.